. In control cells, the activity of these kinases is very low. The remaining two kinases, deoxyadenylic acid (dAMP) and thymidylic acid (dTMP), which are present in higher amounts than dCMP and dGMP kinases in controls and supplements, are unaffected by DNA degradation products and orthophosphate. The availability of all four deoxynucleoside triphosphates in stimulated virulent cells appears responsible for the preferential synthesis of DNA. Of the components in the supplement, only the oligonucleotides and phosphate, alone or in combination, stimulate the activity of dCMP and dGMP kinases; deoxynucleosides and deoxynucleotides are without effect in this respect. Nevertheless, the observation that enhanced DNA synthesis does not occur unless deoxynucleosides and deoxynucleotides are present suggests that a large pool of substrates is required for this enhancement. This report describes the ability of the supplement to stimulate uptake of some of its component parts, namely, the deoxynucleosides.
Encapsulated (virulent) pneumococci of several types synthesize deoxyribonucleic acid (DNA) at a rate greater than that for synthesis of protein and ribonucleic acid (RNA) in resting-cell suspensions supplemented with DNA degradation products and orthophosphate (Firshein, 1961 (Firshein, , 1965 . The DNA degradation products capable of stimulating DNA synthesis in virulent strains consists of an oligo(deoxy)nucleotide fraction (derived from a deoxyribonuclease-treated calfthymus DNA) further supplemented with all eight of the naturally occurring deoxynucleosides and deoxynucleotides. Orthophosphate enhances the activity of the DNA degradation products, but is inactive by itself in stimulating DNA synthesis. RNA degradation products, purines and pyrimidines, and yeast extract have all been found to be ineffective in this respect. Oligo-(deoxy)nucleotides and phosphate fail to produce any stimulation of DNA synthesis unless supplemented by deoxynucleosides and deoxynucleotides. By themselves, deoxynucleosides and deoxynucleotides produce only slight effects.
Cell-free extracts derived from virulent cells of type III exposed to the supplement exhibit greater deoxycytidylic acid (dCMP) and deoxyguanylic acid (dGMP) kinase activity than do control cells (Firshein, 1965) . In control cells, the activity of these kinases is very low. The remaining two kinases, deoxyadenylic acid (dAMP) and thymidylic acid (dTMP), which are present in higher amounts than dCMP and dGMP kinases in controls and supplements, are unaffected by DNA degradation products and orthophosphate. The availability of all four deoxynucleoside triphosphates in stimulated virulent cells appears responsible for the preferential synthesis of DNA. Of the components in the supplement, only the oligonucleotides and phosphate, alone or in combination, stimulate the activity of dCMP and dGMP kinases; deoxynucleosides and deoxynucleotides are without effect in this respect. Nevertheless, the observation that enhanced DNA synthesis does not occur unless deoxynucleosides and deoxynucleotides are present suggests that a large pool of substrates is required for this enhancement. This report describes the ability of the supplement to stimulate uptake of some of its component parts, namely, the deoxynucleosides.
MATERIALS AND METHODS
General methods. The strain of pneumococcus (Diplococcus pneumoniae) used in the previous investigation on kinase activity (A66, type III; Firshein, 1965) was employed in the present study. Preparation of growth medium for resting-cell studies, suspending medium, and procedures for preparation and use of DNA degradation products and phosphate, were all reported previously (Fir-337 FIRSHEIN AND GARGAN shein, 1961 , 1965 . RNA degradation products were prepared in the same manner as their DNA counterparts.
Uptake experiments with C'4-deoxynucleosides. At various times during an experiment with cell suspensions, controls and supplements were pulsed for 2 min with one of the four C14-deoxynucleosides (Schwarz Laboratories, Inc., Mt. Vernon, N.Y.). Since the supplemented suspensions already contained a high concentration of the deoxynucleoside that was being tested (in its nonradioactive form), it was necessary to add an equivalent amount of this nonradioactive deoxynucleoside to the control suspensions to yield identical isotope-carrier ratios in controls and supplements. After the 2-min pulse, the cells were centrifuged in the cold (4 C), washed three times with cold 0.02 M sodiumpotassium phosphate buffer (pH 7.5), and resuspended in the same phosphate buffer. Samples (1 ml) were plated on concentric-ring steel planchets and subsequently dried in an oven at 60 C. The remaining suspension was diluted sixfold for turbidity measurements at 500 m,i inna Klett colorimeter. From the supernatant fluids of the first two washes, 1-ml samples were plated to In other experiments involving uptake of Cl4-deoxynucleosides, supplemented and control cells were centrifuged after 25 min of incubation at 37 C and washed three times in cold sodium-phosphate buffer (pH 7.5). The cells were resuspended in fresh unsupplemented medium, and 30 min at 4 C were allowed to elapse to bring metabolism to a uniformly low level. After incuabtion at 37 C, the same pulse experiment was repeated as described above. Finally, the pulse experiments were performed in the presence and absence of the supplement and glucose.
Extraction of C'4-deoxynucleosides from cells.
After a 1-min pulse with any of the C14-deoxynucleosides, supplemented and control cells were centrifuged in the cold and washed three times with cold soditum-potassium phosphate buffer (0.02 M, pH 7.5). A sample of the cell suspension was plated and counted to give the total amount of C'4-deoxynucleoside bound to the cells. The cells were extracted four times with cold 5% trichloroacetic acid for 30 min at 4 C. The cell debris was removed by centrifugation after each extraction and saved for DNA extraction and measurement as described previously (Firshein, 1961) . A sample of the combined extracts was chromatographed by descending chromatography on Whatman no. 1 paper for 24 hr at 15 C in a solvent consisting of water-saturated butanol and 10 N NH40H (100:1, v/v). Known C'4-deoxynucleosides were also chromatographed. The paper strip (after drying) was scanned for radioactive areas by use of a Vanguard Chromatogram scanner model 880, and spots were detected by ultraviolet light (2,538 A). The RF value of the radioactive spot was compared with the RF of the known C'4-deoxynucleoside.
RESULTS
Effect of supplement on uptake of C'4-deoxynuclesides. Previous results (Firshein, 1960 (Firshein, , 1961 demonstrated that virulent strains of several types incorporated deoxynucleosides into DNA to a greater extent than did their avirulent relatives. However, when other DNA degradation products (the remaining deoxynucleosides, deoxynucleotides, and oligodeoxynucleotides) and orthophosphate were added to virulent cell suspensions in conjunction with the specific deoxynucleoside being tested, such deoxynucleosides were incorporated into DNA to an even greater extent than by themselves. Avirulent cells did not respond to the supplement (i. e., oligonucleotides, phosphate, and all eight of the deoxynucleosides and deoxynucleotides). It was suspected that an active permeation system was involved in this incorporation process and that the supplement may have stimulated such a system. To test whether specific permeability factors were involved, the following experiments were performed. (i) Rates of uptake of C14-deoxynucleosides were determined in control and supplemented-cell suspensions of type III pneumococci. (ii) An attempt was made to extract the cell-bound C14-deoxynucleosides to ascertain whether such deoxynucleosides were altered in any way by the uptake process. (iii) The sensitivity of the uptake process to chloramphenicol was determined in control and supplemented cells. (iv) The dependence of the uptake of C'4-deoxynucleosides in both controls and supplements on an energy source (glucose) was determined. Finally (v), the persistence of factors influencing uptake of C14-deoxynucleosides was determined after removal of the supplement. Figure 1 shows that in the presence of the supplement, a significant increase occurs in rates of uptake of C14-deoxynucleosides in strain A66 as compared with control A66 cells. The uptake is stimulated most for C'4-thymidine and C'4-deoxyguanosine, and to a lesser extent for Cu4-deoxycytidine and C'4-deoxyadenosine. Figure 2 demonstrates that increased uptake of C14-deoxynucleosides does not persist once the supple- the same in cell suspensions where the supplement was removed after a period of time, and in suspensions which had never been exposed to the supplement. Figure 3 shows that chloramphenicol causes a significant delay in uptake of C'4-deoxynucleosides in supplemented cells, but hardly any delay is noted in controls when the antibiotic is present. Table 1 shows that between 80 and 90% (depending on the C'4-deoxynucleoside) of the accumulated radioactivity associated with the cells, after a pulse of 1 min with any of the C14-deoxynucleosides in the presence of the supplement, is extracted by cold trichloroacetic acid. Chromatographic analysis of the extracts shows a spot which corresponds, with respect to RF values, to the known C14-deox-ynucleoside under Fig. 1 . The 1-min pulse was given between 24 and 25 min of incubation. For concentration of C14-deoxynucleosides, see Fig. 1 . Fig. 1 . Glucose is a normal constituent of the suspending medium. In this experiment, it was omitted and added at a final concentration of 1.0%. dA = C14-deoxyadenosine; dG = C14-deoxyguanosine; dC = C14-deoxycytidine; dT = C14-thymidine.
examination. The lack of total recovery can be attributed to incorporation of the precursor into DNA during the pulse. Finally, the omission of glucose from the suspending medium in supplemented or control-cell suspensions results in a 99% inhibition of uptake of the purine C14-deoxynucleosides and a 90% inhibition of uptake of the pyrimidine C54-deoxynucleosides (Table 2) . Effects of components of the supplement on uptake of C14-deoxynucleoside. Each major component of the supplement was tested for its ability to influence uptake of specific C14-deoxynucleosides. Figure 4 shows that all major components of the supplement stimulated uptake of specific C14-deoxynueleosides, with the possible exception of the oligonucleotides. This observation was in contrast to the effects of the supplement components on deoxynucleotide kinase activity (Firshein, 1965) , where only oligonucleotides and phosphate stimulated kinase activity. In the present experiments, deoxynucleoside and deoxynucleotide mixtures stimulated uptake of specific C'4-deoxy- nucleosides during initial incubation stages (up to 10 min), whereas phosphate alone, or in combination with oligonucleotides, enhanced uptake during later incubation stages. Most of the effects of the oligonucleotide-phosphate mixture were due to the anion; oligonucleotides were only slightly effective in stimulating uptake of deoxynucleosides. Further experiments with single deoxynucleosides and deoxynueleotides demonstrated that not all of these components participated in the enhancement of uptake of any specific C'4-deoxynucleoside (Table 3) 6 NS * dA = deoxyadenosine; dG = deoxyguanosine; dC = deoxycytidine; dT = thymidine; dAMP = deoxyadenylic acid; dGMP = deoxyguanylic acid; dCMP = deoxycytidylic acid; dTMP = thymidylic acid; NS = no stimulation; I = inhibition of uptake as compared with controls; NT = not tested. For concentration of deoxynucleosides and deoxynucleotides, see Fig. 1 . acted similarly in the case of C'4-deoxycytidine uptake. In general, a deoxynucleoside was more effective than a deoxynucleotide in stimulating uptake of another deoxynucleoside. Deoxyadenosine was particularly effective in enhancing uptake of the C 4-pyrimidine deoxynucleosides, and any of the remaining deoxynucleosides could stimulate uptake of a purine deoxynucleoside.
Effect of other metabolites on uptake of C14-deoxynucleosides. It may be argued that the supplement contains factors (particularly phosphate) which affect the overall rate of metabolism in virulent cells, and that the stimulatory effects of the supplement on uptake of deoxynucleosides may be nonspecific. Table 4 shows the effects of RNA degradation products and yeast extract, with and without phosphate, on uptake of C14-deoxynucleosides in strain A66. In no instance were effects similar to those of the regular supplement obtained. Addition of phosphate to cell suspensions containing RNA degradation products or yeast extract resulted in an enhancement of uptake of C'4-deoxynucleosides only to the extent of phosphate alone.
DISCUSSION
The foregoing data have shown that when specific C'4-deoxynucleosides are added to suspensions of type III pneumococci in conjunction with the remaining deoxynucleosides, other DNA degradation products, and orthophosphate, such C14-deoxynucleosides are taken up by the cells at a greater rate than when they are present by themselves. This high rate of uptake of C'4-deoxynucleosides may be due to the stimulation of the activity of permease systems by various components of the supplement. Cohen and Monod (1957) have defined a permease system as "all the components, inducible proteins, noninducible and less specific components involved in the uptake of a specific metabolite." The evidence for the stimulation of permease systems is based upon the following observations. First, the rate of uptake of any specific C'4-deoxynucleoside is increased when the supplement is present. Second, chloramphenicol depresses the rate of uptake of C'4-deoxynucleosides to control values in supplemented-cell suspensions, but has no effects on uptake in control-cell suspensions. Third, the concentrating mechanism does not alter the C14-deoxynucleosides after uptake; most of the com-
